U.S. company to strengthen Qiagen’s forensic services portfolio

Life sciences company Qiagen said it has acquired DNA biometrics company Verogen, strengthening its forensic services portfolio.

The deal builds on the companies’ existing partnership since 2021, under which Qiagen has rights to distribute some Verogen products, such as next-generation gene sequencing panels and GEDmatch genetic code analysis technology.

Qiagen expects sales of the Verogen portfolio to be about $20 million this year.

San Diego-based Verogen, founded in 2017, provides DNA-based human identification products and services that are used in forensic science and help solve criminal and missing-persons cases.

Verogen’s portfolio will complement Qiagen’s sample collection and preparation kits, which are used to isolate human DNA from samples for forensic testing and analysis.